Neuronal Subtype-Specific Genes that Control Corticospinal Motor Neuron Development In Vivo  by Arlotta, Paola et al.
Neuron, Vol. 45, 207–221, January 20, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.neuron.2004.12.036
Neuronal Subtype-Specific Genes that Control
Corticospinal Motor Neuron Development In Vivo
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tiation of distinct neuronal subtypes (Rallu et al., 2002).
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Although decades of elegant studies into cortical devel-Summary
opment have provided remarkable knowledge about the
anatomical and cellular organization of the mammalianWithin the vertebrate nervous system, the presence
cortex, the genetic mechanisms that control its complexof many different lineages of neurons and glia compli-
neuronal development and diversity are much lesscates the molecular characterization of single neu-
known.ronal populations. In order to elucidate molecular
In this report, we focus on the critical population ofmechanisms underlying the specification and devel-
corticospinal motor neurons (CSMN), located primarilyopment of corticospinal motor neurons (CSMN), we
in cortical layer V, and directly identify genetic determi-purified CSMN at distinct stages of development
nants of this specific neuronal subtype. CSMN (“upperin vivo and compared their gene expression to two
motor neuron”) degeneration is a key component ofother pure populations of cortical projection neurons:
motor neuron degenerative diseases, including amyo-
callosal projection neurons and corticotectal projec-
trophic lateral sclerosis (ALS), and CSMN injury contrib-
tion neurons. We found genes that are potentially in- utes critically to the loss of motor function in spinal cord
structive for CSMNdevelopment, aswell as genes that injury. The anatomical and morphological development
are excluded from CSMN and are restricted to other of CSMN has been extensively characterized (Jones et
populations of neurons, even within the same cortical al., 1982; Terashima, 1995), but strategies to repair
layer. Loss-of-function experiments in null mutant CSMN are limited by a lack of understanding of the
mice forCtip2 (also known asBcl11b), one of the newly molecular controls over CSMN development, including
characterized genes, demonstrate that it plays a criti- neuron type-specific differentiation, survival, and con-
cal role in the development of CSMN axonal projec- nectivity.
tions to the spinal cord in vivo, confirming that we A few isolated molecules specifically associated with
identified central genetic determinants of the CSMN CSMNand related cortical neurons have been identified.
population. These include Otx1, a transcription factor expressed in
layers V and VI (Frantz et al., 1994; Weimann et al.,
Introduction 1999); Er81, a transcription factor of unknown function
expressed by multiple neuronal subtypes in layer V
(Hevner et al., 2003); and molecules involved in axonalDuring the development of the central nervous system,
pathfinding expressed in several types of neurons, in-neuronal progenitors undergoprecise stepwisedifferen-
cluding those with projections along the corticospinaltiation to ultimately produce the complex variety of neu-
tract (Coonan et al., 2001; Rolf et al., 2002).ronal subtypes that populate thematurebrain. Extensive
Gene expression studies used to detect transcriptswork has progressively unraveled the molecular mecha-
that are present in only selected neocortical neurons ornisms controlling processes of early neuronal specifica-
that are expressed at low levels are typically compli-tion and has identified transcription factors and fate
cated by the cellular heterogeneity of the neocortexdetermination genes that mediate early aspects of neu-
(Geschwind, 2000). This is a more general problem ofrogenesis in several regions of the CNS (Bertrand et al.,
gene expression studies in the CNS, which has led to
the development of approaches aimed at simplifying the
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sues (Diaz et al., 2002). Application of these approaches after dissociation and then were FACS purified (Figures
1R and 1S). After FACS, P14 CSMN retain elements ofto the analysis of neuronal subtype-specific genes in
neocortex is fundamentally limited by the substantial their original in vivo morphology, including a proximal
apical dendrite and occasionally a proximal axon (Fig-lack of antigenic markers with which to discriminate
among different neuronal subtypes. ure 1S).
As comparison neuronal populations, we purified in-We overcame these issues by purifying CSMN and
two closely inter-related neuronal subtypes (callosal terhemispheric callosal neurons, a subset ofwhich share
lamina V location with CSMN, providing insight intoprojection neurons and corticotectal projection neu-
rons) from murine neocortex at four distinct stages of genes that are cell type specific rather than laminar
specific; and corticotectal neurons, which share withdevelopment (E18, P3, P6, andP14), using fluorescence-
activated cell sorting (FACS). These stages span critical CSMN both location in lamina V and overlapping early
developmental extension of subcerebral projections.events of CSMN specification, morphologic maturation,
and connectivity. Using microarrays, we compared the Corticotectal neurons might allow the identification of
genes unique to CSMN among other highly related layergene expression of purified CSMN and these two other
pure neuronal subtypes. We hypothesized that there are V subcerebral projection neurons. These data demon-
strate that CSMNand other subtypes of cortical neuronslikely many genes that are common to all projection
neurons and that there is a smaller number of genes can be purified from the complex and heterogeneous
neocortex at distinct and critical developmental stagesthat are more specific to closely related subtypes of
projection neurons (e.g., CSMN, corticotectal neurons, in vivo.
or other subcerebral projection neurons, but not callosal
neurons). Ultimately, the specification of CSMN most Expression Profiling of Projection
likely derives from the overlapping combinatorial ex- Neuron Subtypes
pression of a specific program of genes in CSMN. We Gene expression analysis in brain is generally compli-
find genes that are progressively restricted and specific cated by the coexistence of many different cell types,
to CSMN, as well as genes excluded from CSMN and resulting in high background noise and the inability to
restricted to other neuronal populations, even within the detect small differences in cell type-specific gene ex-
same cortical layer. Confirmatory analysis of CSMN- pression. The purification of single populations of corti-
specific gene expression for selected candidate genes cal projection neurons allows us to overcome these diffi-
of particularmechanistic interest and functional analysis culties and compare the expression profiles of distinct
in mutant mice in vivo indicate that these genes are part neuronal populations without confounding contamina-
of a combinatorial program of novel genetic determi- tion by other cell types. We used pure populations of
nants of the CSMN population. CSMN from E18, P3, P6, and P14 mice and compared
them by microarray (Affymetrix 430A GeneChips) to two
other neuronal types: callosal neurons and corticotectalResults
neurons. To control rigorously for biological sample vari-
ability, at each age we used CSMN, callosal neurons,Purification of Corticospinal Motor Neurons
and corticotectal neurons from two independent sam-To identify genes that control cell type specification and
ples derived from different litters and independentlydifferentiation of CSMN, we compared gene expression
FACS purified and hybridized (true biological replicates)profiles of CSMN to two other pure populations of corti-
(Supplemental Figure S1E [http://www.neuron.org/cgi/cal projection neurons: callosal projection neurons and
content/full/45/2/207/DC1/]). To assess the consistencycorticotectal projection neurons.
of the microarray data, we compared gene expressionCSMN were retrogradely labeled by injecting green
between independent homotypic samples (biologicalfluorescent microspheres into their axonal projection
replicates) (Supplemental Figures S1A and S1B) andfields: the pons at E18 and P3 and the cervical spinal
between heterotypic samples (different neuronal sub-cord at P6 and P14. Embryonic injections were per-
types) (Supplemental Figures S1C and S1D). Prior toformed under ultrasound guidance to accurately control
normalization, correlation coefficients for biological rep-the injection location (Figures 1A–1C). This strategy spe-
licates ranged from 0.94 to 0.99 (Supplemental Figurecifically labels CSMNsomas in sensorimotor cortex (Fig-
S1E) and hybridization replicates were all 0.99. Theseure 1D) based on their axonal projections, at four ages
comparisons indicate that geneexpression is very highlyranging from early postmitotic (E18) to more differenti-
consistent between biological replicates, whereasmanyated (P3–P6) tomore mature and synaptically integrated
genes are differentially expressed in heterotypic com-neurons (P14) (Figures 1E–1H). Similar techniques were
parisons, supporting the reliability of the dataset.used to label callosal neurons (Figures 1I–1L) and corti-
cotectal neurons (Figure 1M). Dissociated, labeled CSMN
were purified by FACS to typically 99% purity (Fig- Distinct Classes of Cortical Projection Neurons
Share Clusters of Developmentallyures 1N–1S).
CSMN were collected for RNA isolation immediately Regulated Genes
The development of CSMN is likely controlled by a com-following FACSpurification. Even thoughCSMNare very
fragile neurons, acutely FACS-purified E18, P3, and P6 bination of (1) general molecular pathways common to
all projection neurons and (2) a specific combination ofCSMN are viable and can be cultured in vitro (Ozdinler
et al., personal communication), confirming their health genes highly enriched or restricted to CSMN. To obtain a
global view of genes in the first set, we used hierarchicalfollowing FACS. Because neurons at P14 are even more
fragile, P14 CSMN were fixed in RNAlater immediately clustering to examine changes in gene expression as
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Figure 1. Population-Specific FACS Purification of CSMN, Callosal Neurons, and Corticotectal Neurons during Development In Vivo
(A–C) In utero ultrasound-guided microinjection of fluorescent microspheres into the pons of an E17 mouse embryo showing (A) the initial
positioning of the glass micropipette (arrowheads), (B) injection at the pons/midbrain junction (arrow), and (C) the pons postinjection. (D)
Dorsal view of a P14 brain retrogradely labeled from the C5 level of the cervical spinal cord, showing labeling of CSMN in sensorimotor cortex.
(E–H) CSMN and (I–L) callosal projection neurons (CPN) labeled with green fluorescent microspheres in E18, P3, P6, and P14 neocortex. (M)
Sagittal P14 brain section, showing labeling of CSMN (red; arrowheads) and corticotectal projection neurons (CTPN; green; arrows), in the
same mouse. Labels II/III and V indicate cortical laminae; pia, pial surface; ob, olfactory bulb; cb, cerebellum. (N and Q) Sample FACS plot
of the population of CSMN selected; CSMN are selected as (N) a highly fluorescent population (R2; right peak) and (Q) based on size (forward
scatter) and surface characteristics (side scatter). (O and R) Mixed cortical cells before FACS purification; only a very small percentage of
dissociated cells are CSMN (arrows). (P and S) FACS purification of CSMN results in an essentially pure, retrogradely labeled population. (S)
FACS purified P14 CSMN fixed in RNAlater often retain short proximal dendritic and/or axonal processes. Scale bars, (A–C) 500 m, (E–M)
100 m, (O, P, R, and S) 20 m, (S) 10 m.
cortical projection neurons differentiate and mature opment of distinct classes of cortical projection neurons
is controlled by a large number of genes common to(Supplemental Figure S2A [http://www.neuron.org/cgi/
content/full/45/2/207/DC1/]). As expected, we found all projection neuron subtypes, in combination with a
smaller set of subtype-restricted molecules.that the majority of genes are expressed with similar
profiles in different projection neuron subtypes (Supple- This analysis also shows that P14 CSMN are molecu-
larly very similar to corticotectal neurons, while both aremental Figures S2B–S2D and B.J.M. et al., unpublished
data). These data support the hypothesis that the devel- distinct from callosal neurons (data not shown). This
Neuron
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likely reflects the fact that both CSMN and corticotectal suo-Takasaki et al., 2000); Pcp4 (Sangameswaran et al.,
1989); S100a10 (Saris et al., 1987);Mu-Crystallin (Sego-neurons may have similar requirements for survival and
via et al., 1997); Netrin-G1 (Yin et al., 2002); Cadherinsubcerebral connectivity.
13 (Huang et al., 2003); Cadherin 22 (Sugimoto et al.,
1996); and one novel EST that we name Csmn1. TheseIdentification of CSMN-Specific Genes
are all largely undescribedmolecules in cortex that haveTo identify CSMN-specific genes, we assessed the sig-
microarray expression profiles strongly indicating sub-nificance of differences in gene expression among neu-
type-specific expression inCSMNand/or other subcere-ronal subtypes by pairwise comparisons at each age,
bral projection neurons (Figures 3B and 3D–3P).using the SAMmethod.We selected the 100most signif-
We find that all of these genes have high levels oficant genes from each pairwise comparison of all three
expression in layer V of cortex, where they are stronglyneuronal populations performed at each age (total of
expressed in morphologically identified CSMN (Figures884 unique genes) and further analyzed the trend of
3A–3P), confirming and extending the microarray re-expression of each individual gene to define a smaller
sults. By in situ hybridization, these genes showdifferentset of molecules of potentially high biological relevance.
degrees of restriction to CSMN. Three genes—Diap3,We identified genes specifically expressed in CSMN
Igfbp4, andCrim1—demonstrate particularly interestingaswell as genes specific to callosal neurons and cortico-
and very restricted patterns of expression that distin-tectal neurons that, importantly, serve as negative mo-
guish CSMN from other subcerebral projection neurons.lecular markers of CSMN. Some of the most biologically
Diap3 is expressed only in sensorimotor layer V whereand statistically significant genes are described in Fig-
CSMN are located, while it is not expressed in moreure 2. These genes were classified into one of six groups
lateral (Figure 3A) or caudal (Figure 3B) areas of layer Vbased on expression profiles suggestive of a specific
where other subcerebral projection neurons (e.g., corti-role in distinct aspects of CSMN development: (1) genes
cotectal neurons) are located. Igfbp4 exhibits a similarthat are expressed at higher levels in CSMN at all stages
degree of restriction to CSMN in sensorimotor layer Vof development (Figure 2A) and might be important for
(Figures 3C and 3D), although it is also expressed inthe establishment and maintenance of CSMN identity;
other populations in layers II/III and VI. Crim1 is re-(2) genes that are highly expressed in CSMN early in
stricted to layer V, with high level expression in rostraldevelopment (Figure 2B) and might be important for
sensorimotor cortex (Figure 3E). These three genes ap-early CSMN specification; (3) and (4) genes that exhibit
pear to be area-specific markers that identify the loca-increasing levels of expression as CSMN develop and
tion of CSMN in layer V along mediolateral and rostro-might control intermediate and later aspects of CSMN
caudal axes.differentiation, such as process outgrowth and synapse
A larger groupof genes—Ctip2,Encephalopsin,Clim1,formation (Figures 2C and 2D); (5) genes that are ex-
Fez, Pcp4, and S100a10—appear to be expressed inpressed at higher levels in CSMNcompared to the highly
CSMN and the broader class of closely related subcere-related population of corticotectal neurons (Figure 2E)
bral projection neurons in layer V (Figures 3F–3K). Inand are representative of the small class of genes that
contrast, Mu-Crystallin and Netrin-G1 appear to be ex-
differentiate CSMN from other subcerebral projection
pressed only in some CSMN and subcerebral neurons
neurons of layer V; (6) genes that are negativemarkers of
of layer V (Figures 3L and 3M) andmay delineate distinct
CSMN but that are expressed in callosal or corticotectal
functional classes. Consistent with the microarray data,
neurons (Figure 2F). Expression trends of these genes other genes—Csmn1, Cadherin 13, and Cadherin 22—
are shown in Figure 3 and Supplemental Figure S3 show less restricted patterns of expression but are ex-
(http://www.neuron.org/cgi/content/full/45/2/207/ pressed at much higher levels in subcerebral neurons
DC1/). (Figures 3N–3P). Together, these data support the hy-
The CSMN genes identified include transcription acti- pothesis that a small number of CSMN restricted genes,
vators and repressors (e.g., Ctip2 [also known as along with a larger group of genes that are also ex-
Bcl11b], Bcl6, Sox5); zinc finger domain-containing pro- pressed in other subcerebral neurons, define the molec-
teins (e.g., Fez); cell surface proteins and receptors (e.g., ular phenotype of CSMN.
Encephalopsin, Itm2a, Daf1); calcium signaling mole- To further confirm the cellular identity and projection
cules (e.g., Pcp4, S100a10); genes involved in neuronal neuron type of labeled cells identified by in situ hybrid-
specification (e.g., Crim1), cell adhesion (e.g., Cdh22, ization, we combined in situ hybridization with retro-
Cdh13, Cntn6), and axon guidance (e.g., Neto1, Netrin grade labeling in the same tissue. We retrogradely la-
G1); as well as genes involved in critical pathways like beled CSMNwith DiI, photoconverted the DiI to a visible
the thyroid hormone and IGF signaling cascades (e.g., cytoplasmic precipitate, and performed nonradioactive
Mu-Crystallin, Igfbp4). in situ hybridization. Combining these methods allows
To confirm CSMN-specific gene expression and vali- the colocalization of the DiI photoconverted precipitate
date themicroarray data, weperformed in situ hybridiza- and the in situ hybridization signal, enabling us to iden-
tion or immunocytochemistry for 14 selected genes (Fig- tify CSMN expressing individual genes. We investigated
ure 2, bolded) chosen for their particularly interesting four genes from Figure 3 and confirmed that CSMN
patterns of expression and potential function based on expressMu-Crystallin (Supplemental Figures S4A, S4B,
protein domains or literature from other systems. We and S4B [http://www.neuron.org/cgi/content/full/45/2/
choseDiap3 (Olson, 2003); Igfbp4 (Stenvers et al., 1994); 207/DC1/]), Fez (Supplemental Figures S4C, S4D, and
Crim1 (Kolle et al., 2000); Ctip2 (Avram et al., 2000); S4D), Encephalopsin (Supplemental Figures S4E, S4F,
Encephalopsin (Blackshaw and Snyder, 1999); Clim1 and S4F), and Crim1 (Supplemental Figures S4G, S4H,
and S4H).(also known as Ldb2) (Bulchand et al., 2003); Fez (Mat-
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Figure 2. A Subset of CSMN-Specific Genes from Microarray Analysis, Classified Based on Expression Profiles Suggesting Biological Roles
during CSMN Development
A subset of biologically interesting genes is shown, selected from a larger group of differentially expressed genes. Each group is represented
by a prototypical expression profile shown at left. The genes shown in bold are those selected for further analysis in this study. (A) Genes
that are expressed at higher levels in CSMN at all stages of development; (B) genes that are highly expressed in CSMN early in development;
(C and D) genes that exhibit increasing levels of expression as CSMN develop; (E) genes that are expressed at higher levels in CSMN compared
to the closely related population of corticotectal neurons; and (F) genes that are expressed at high levels in other populations of cortical
projection neurons, but not in CSMN, thus serving as negative markers for CSMN. Graphic gene expression profiles are shown for all other
genes listed either in Figure 3 (for those listed in bold) or in Supplemental Figure S3.
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These data provide strong evidence that we identified To test the hypothesis that CTIP2 controls some as-
pects of CSMN and subcerebral projection neuron de-novel or previously uncharacterized genes that are spe-
cific to CSMN. Of interest, while all are expressed by velopment, we first defined its cell type-specific pattern
of expression in cortex and confirmed that it is ex-CSMN, each has a different pattern of expression, and
it is likely their combinatorial interaction that defines pressed at high levels in CSMN and corticotectal neu-
rons, but not callosal neurons. In addition to the predom-CSMN. Together with negative markers, they allow pro-
gressive definition of the molecular phenotype of inant population of subcerebral projection neurons in
layer V that express CTIP2 at very high levels, we alsoCSMN in vivo.
observed a much lower level of CTIP2 expression in
corticothalamic neurons and GABAergic neurons (B.J.M.Lmo4 Is Not Expressed in CSMN and Is Restricted
et al., unpublished data).to Callosal Neurons in Layer V
We found that CTIP2 is expressed at high levels inAs cell fate specification and maturation of CSMN will
layer V of cortex in a pattern that extends across thelikely depend on both positive and negative molecular
entire rostrocaudal (Figure 4A) and mediolateral (Figuredeterminants, we further characterized one additional
5D) aspects of cortex. This is consistent with our mi-gene, Lmo4 (Supplemental Figure S5A [http://www.
croarray data, showing high levels of expression in bothneuron.org/cgi/content/full/45/2/207/DC1/]), a LIM
CSMN and corticotectal neurons. Since high level CTIP2domain-containing protein known to be expressed in
expression extends beyond the boundaries of motorlayers II/III and V (Bulchand et al., 2003), although its
cortex but is restricted to layer V, we hypothesized thatcell type-specific expression within these layerswas not
CTIP2 is expressed at high levels in all subcerebral pro-previously known. Lmo4 and other genes expressed in
jection neurons, but not in cortico-cortical projectioncallosal or corticotectal neurons but not inCSMN (Figure
neurons (e.g., callosal neurons) or in other locally inte-2F) can serve as negative markers of CSMN.
grated neurons of layer V.Microarray analysis indicated that Lmo4 is specifically
To test this hypothesis, we performed a series of ex-expressed in callosal neurons but not in CSMN (Figure
periments in which we selectively retrogradely labeled2F).We confirmed and extended these results and found
individual populations of projection neurons. First, weby immunocytochemistry that LMO4 is expressed in all
injected FluoroGold (FG) into the pyramidal tract at thecallosal neurons but not inCSMN (Supplemental Figures
pons-midbrain junction to label subcerebral projectionS5A–S5L [http://www.neuron.org/cgi/content/full/45/2/
neurons (Figure 4B). We found that all subcerebral pro-207/DC1/]). These data demonstrate that LMO4 is a neu-
jection neurons located in layer V expressed CTIP2 atronal subtype-restricted gene and, most importantly to
high levels (Figures 4C and 4H–4K). Next, we labeledthe present study, is a negative marker of CSMN that
CSMN specifically via FG injections into the cervicaldistinguishes CSMN from other neuronal types within
spinal cord and confirmed that all CSMN express CTIP2layer V.
at high levels (Figures 4D–4G). Conversely, FG labeling
of callosal neurons via injection in contralateral cortex
CTIP2 Is Expressed in CSMN but Not
revealed that CTIP2 was not expressed by the relatively
in Callosal Neurons in Layer V
small number of callosal neurons in layer V, where CTIP2
To begin to understand the functional roles of selected
expression is highest (Figures 4L–4O), nor by callosal
CSMN-specific molecules, we characterized more pre-
neurons in layer II/III or layer VI (B.J.M. et al., unpublished
cisely the CSMN expression of Ctip2, a gene of yet
data). Together, these data demonstrate that CTIP2 is
unknown function in the brain that shows a very high
a neuronal subtype-specific, not simply a layer-specific,
level of expression in layer V in both CSMN and cortico-
marker of CSMNandother evolutionarily related popula-
tectal neurons (Figures 3F, 3F, and 4A). Very recent
tions of neurons with subcerebral projections.
studies have shown that COUP-TF1 interacting protein
2 (CTIP2) has critical roles in the immune system, con-
trolling T cell subtype specification and survival in the CTIP2 Is Expressed in Developing Cortical Plate
and in CSMN in Layer Vdeveloping thymus (Wakabayashi et al., 2003). These
data suggested to us that itmight have similar, yet undis- To better understand the functional role of CTIP2 in
CSMN development, we investigated its temporalcovered, roles in specification, maintenance, and/or
connectivity of distinct neuronal populations in the ner- course of expression through embryonic and postnatal
cortical development. At E12, when early cortical pro-vous system, specifically of CSMN and other subcere-
bral projection neurons. genitors are dividing, CTIP2 is expressed in only a small
Figure 3. Genes Identified from the Microarray Analysis Are Expressed in CSMN
(A–P) In situ hybridization in coronal (A, C, and E–P) or sagittal (B and D) sections of cortex, showing specific expression of all 14 genes
selected in the morphologically distinct population of CSMN (insets, enlarged from boxed areas; small arrows) in layer V. Red arrows indicate
the limit of gene expression in the mediolateral (A, C, and E) and rostrocaudal (B and D) axes. Black arrows in (B) and (D) indicate sensorimotor
cortex, where Diap3 and Igfbp4 are expressed; arrowheads indicate visual cortex where Diap3 and Igbp4 expression was not detected. Ages
are P0 (Pcp4), P3 (CTIP2, Cadherin 13, S100a10), P6 (Crim1, Clim1), P14 (Diap3, Igfbp4, Fez, Encephalopsin, Mu-Crystallin, Netrin-G1, Csmn1,
Cadherin 22). (B, and D–P) Temporal profiles of gene expression from microarray analysis of each selected gene in CSMN (blue) and callosal
neurons (red). Bars indicate standard errors of the mean. Expression in corticotectal neurons (CTPN) closely resembles that in CSMN (data
not shown), with the exception of a restricted set of genes that discriminate between these closely related projection neuron populations
(e.g., Diap3, Igfbp4, and Crim1). Scale bars, (A–P) 100 m, ([A–P], inset) 20 m.
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Figure 4. CTIP2 Is Expressed in CSMN and Subcerebral Projection Neurons of Layer V but Not in Callosal Neurons
(A–C) Sagittal mouse brain section at P6, showing (A) labeling of large projection neurons in layer V with anti-CTIP2 antibody (arrows) and (B)
FG labeling of subcerebral projection neurons in layer V. (C) Merge of (A) and (B), showing CTIP2 expression in subcerebral projection neurons.
(D) Coronal section of cortex at P6, showing high levels of CTIP2 expression in layer V (red) and FG staining of CSMN in the same layer
(green). (E) High-magnification FG labeling of CSMN and (F) CTIP2 expression in the boxed area in (D). (G) Merged image of (E) and (F),
showing CTIP2 expression in all CSMN. (H) Coronal section of cortex at P6, showing high levels of CTIP2 expression in layer V (red) and FG-
labeled subcerebral projection neurons in layer V (green). (I) High-magnification image of FG labeling of subcerebral projection neurons and
(J) CTIP2 expression in the boxed area in (H). (K) Merged image of (I) and (J), showing CTIP2 expression in essentially all subcerebral projection
neurons. (L) Coronal section of cortex at P6, showing high levels of CTIP2 expression in layer V (red) and FG-labeled callosal neurons (green).
(M) High-magnification FG labeling of callosal neurons and (N) CTIP2 expression in the boxed area in (L). (O) Merged image of (M) and (N),
showing exclusion of CTIP2 from callosal neurons. Scale bars, (A–C) 100 m, (D, H, and L) 50 m, (E–G, I–K, and M–O) 10 m.
cluster of cells in ventrolateral cortex (Figure 5A). In and other subcerebral projection neurons once they
reach the cortical plate (Figures 5B and 5C). These datacontrast, no cells expressing CTIP2 are visible in either
the ventricular or subventricular zones, where neural suggested that CTIP2 might control final CSMN posi-
tioning in layer V, or, alternatively, CSMN postmitoticprecursors are located that give rise to cortical projec-
tion neurons. This suggests that CTIP2 is not involved in differentiation, including process outgrowth and path-
finding and/or survival. The second alternative appearsearly specification of cortical precursors. At E14, during
peak production of CSMN, and at E16, when themajority more likely because (1) CTIP2 is not expressed in other
neurons that also take position in developing layer Vof CSMN have reached the cortical plate, CTIP2 is highly
expressed by cells in the cortical plate, but not by cells (i.e., callosal neurons); rather, CTIP2 exhibits restricted
expression to CSMN and other related neurons within the ventricular or subventricular zones, suggesting
that CTIP2 begins to be expressed in postmitotic CSMN similar long-distance subcerebral connections (Figure
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pathfinding, resulting in failure of CSMN to connect to
the spinal cord. In addition, in Ctip2/ mice, reduced
CTIP2 expression results in abnormal developmental
pruning of corticospinal axons.
To investigate whether the neocortex of Ctip2/mice
is abnormal, we first compared the cortical architecture
of P0 Ctip2/ mice to wild-type littermate controls. We
labeled cortical layers using markers of distinct cortical
laminae: LMO4 (layers II/III and V); ER81 (layer V); and
TBR1 (layers I andVI and subplate). At the level of cellular
resolution of these markers, the cortex of Ctip2/ mice
appears normal, suggesting that lack of Ctip2 does not
result in widespread death of neuronal populations in
cortex, nor in neuronal lamination defects (data not
shown). While more subtle cytoarchitectural abnormali-
ties might be present and/or cortical neuronal cell death
might occur at later developmental stages, as sug-
gested byour observationofwidespreadneuronal death
in several other CNS areas where CTIP2 is expressed
(B.J.M. et al., unpublished data), the early neonatal le-
thality of Ctip2/mice makes it currently difficult to fully
test these possibilities.
Very interestingly, however, despite the fact that
Ctip2/mice die at P0,well beforeCSMNaxonsconnect
to final targets in the spinal cord, Ctip2/ mice display
striking abnormalities of axonal fiber tracts exiting neo-
cortex and forming the internal capsule. Specifically,
Ctip2/ mice have substantial disorganization of the
cortical axon fascicles that normally perforate the stria-
tum to form the internal capsule (Figure 6). The effect
of CTIP2 in such axonal fasciculation and extension
defects appears specific to only distinct types of subcer-
ebral and/or subcortical axons, since other fiber tracts
(e.g., corpus callosum) appear normal (Figures 6A andFigure 5. CTIP2 Is Expressed in the Developing Cortical Plate and
6D). This is consistent with our findings that callosalin Neocortical Layer V
neurons do not normally express CTIP2 (Figure 4).(A) At E12, no expression of CTIP2 is detected in the preplate (PP);
expression is limited to far lateral developing cortex. (B) At E14, To more closely examine axonal projections of CSMN
CTIP2 is expressed at high levels (arrows) in the developing cortical in Ctip2/ mice, we first compared the corticospinal
plate (CP) and developing striatum (asterisk), but not in the ventricu- fiber tracts of Ctip2/ mice to those of wild-type lit-
lar zone or overlying subventricular zone (dashed line near ventricle, termates at P0, using immunocytochemistry for L1, a
LV). (C) At E16, CTIP2 is expressed in the early developing neurons
member of the CAM family of cell adhesion moleculesof deep cortical layers (arrows) and in the striatum (asterisks). (D)
known to be expressed by CSMN projections and se-Expression is maintained at high levels in layer V of cortex and
lected fiber tracts in the CNS (Fujimori et al., 2000). Westriatum at P3. (E) Sagittal section at P6, showing high-level expres-
sion of CTIP2 in layer V of neocortex along the rostral to caudal found that P0 Ctip2/ mice lacked the typical fascicu-
axis and in the striatum (asterisk), hippocampus (hp), and olfactory lated bundles of subcerebral projection fibers that nor-
bulb (ob). Scale bars, (A–E) 100m.Dotted lines indicate pial surface mally form the internal capsule (n 5). This abnormality
(Pia), corpus callosum (cc), and ventricular margin (LV). is quite distinct along the entire rostrocaudal axis of the
internal capsule (Figures 6B, 6C, 6E–6H, 6J, and 6K).
Interestingly, some highly disorganized and nonfascicu-
4); (2) high levels of CTIP2 expression are observed in lated Ctip2/ axonal projections deviated dramatically
postmitotic immature neurons that have just started to from their normal path (Figure 6K), coursing obliquely
extend an axon (E14–E18); and (3) mice with a targeted and transverse to other axons of the internal capsule.
deletion of COUP-TF1 (a major interacting protein of To illuminate the fine axonal architecture of abnormal
CTIP2) display axonal pathfinding defects (Zhou et al., nonfasciculated internal capsule fibers in Ctip2/ mice,
1999). we performed anterograde DiI tracing of these fiber
tracts by placing DiI crystals in cortex of E18 Ctip2/
Ctip2/ Mice Fail to Form Cortical Connections mice and wild-type controls. Confocal analysis of DiI-
to the Spinal Cord labeled fibers in the internal capsule further confirmed
To test these alternative hypotheses and to define the this axon growth and fasciculation defect by showing
function of CTIP2 in vivo, we investigated homozygous that Ctip2/ axons were present as individual, nonfas-
Ctip2/ and heterozygous Ctip2/ mice (Wakabayashi ciculated, and disorganized fibers (Figures 6I and 6L).
et al., 2003). Ctip2/ mice are born alive but die soon Some disorganized axons possess what appear to be
after birth (P0). We found that, in Ctip2/ mice, CSMN abnormal, bulbous varicosities and dysmorphic growth
cones (Figure 6L) suggestive of those first described byaxons exhibit defects in fasciculation, outgrowth, and
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Figure 6. Ctip2/ Mice Display Defects in
Subcerebral Axon Extension and Fascicula-
tion in the Internal Capsule
(A) Wild-type brain section at P0, stained with
cresyl violet, showing the typical axonal fasci-
cles of the internal capsule (arrows) and cor-
pus callosum. (D) Matched section from a
Ctip2/ null mutant brain, demonstrating the
striking absence of these internal capsule
fascicles (arrows), while the corpus callosum
appears normal. L1-expressing axons in the
internal capsule of P0 wild-type mice ([B and
C]; arrows) are highly fasciculated and tightly
bundled compared to internal capsule axons
of Ctip2/ mice ([E and F]; arrows), which
show distinct lack of fasciculation and strik-
ing disorganization. This abnormality is evi-
dent through the entire rostrocaudal extent
of the internal capsule, shown here at both
rostral (B and E) and caudal (C and F) loca-
tions and in sagittal sections (G and J); DAPI
nuclear staining (blue). (H and K) High-magni-
fication images from the boxed areas in (G)
and (J), respectively, reveal the fine details of
the nonfasciculated Ctip2 null mutant axons
([K]; arrows) compared to large fascicles in
wild-type controls ([H]; arrows); arrowheads
in (K) indicate highly disorganized axonal pro-
jections deviating from their normal path in
theCtip2/ null mutant mice. Anterograde DiI
tracing of axons through the internal capsule
of E18wild-type (I) andmatchedCtip2/mice
(L). Many of the disorganized axons in the
Ctip2/ mice possess bulbous varicosities
suggestive of dysmorphic growth cones
(arrows in [L]). Scale bars, (B, C, E, and F) 100
m; (H and K) 50 m; (I and L) 10 m. ctx,
cortex; cc, corpus callosum; ic, internal cap-
sule; str, striatum; hp, hippocampus.
Ramon y Cajal (Ramon y Cajal, 1928) and more recently Given the extremely high levels of CTIP2 expression
in subcerebral projection neurons, we examined hetero-highlighted and investigated by Silver and colleagues
(Silver, 2004). zygous Ctip2/ mice to determine whether there is a
gene dosage effect on the observed abnormalities.Given these striking abnormalities, we further exam-
ined the outgrowth of subcerebral axonal projections These experiments allowed us to investigate the role of
CTIP2 into adulthood, much later than the P0 age atand the formation of the corticospinal tract in detail.
We performed in vivo anterograde DiI tracing at P0 by which Ctip2/ mice die. Interestingly, we found subtle
defects in fasciculation in the internal capsule inCtip2/injecting DiI into developing sensorimotor cortex of
Ctip2/ mice and matched wild-type littermate con- mice (data not shown), indicating a gene dosage effect.
To investigate the ability ofCtip2/CSMN to properlytrols. Close examination of axons along the length of
the developing corticospinal tract revealed that, while establish and maintain projections to the spinal cord,
we injected FG into the cervical spinal cord of 3- andapproximately normal numbers of axons extend as far as
the hypothalamus, they are disorganized, not normally 10-week-oldCtip2/miceandquantified labeledCSMN
in the entire cortex.During normal development, subcer-fasciculated, and located dorsal to their normal position.
Outgrowing axons also exhibit striking deviations from ebral neurons in layer V of lateral sensory cortex initially
extend an axon to the spinal cord, but only a smalltheir normal path and extend toward ectopic targets
(Figures 7A–7G). Only a small number of axons were percentage of these neuronsmaintain corticospinal pro-
jections into adulthood (Polleux et al., 2001). Quite re-observed caudal to the hypothalamus, and these were
frequently extending in the wrong direction (Figures 7C markably, we find that, at 3 and 10 weeks of age, a large
number of neurons in lateral sensory cortex of Ctip2/and 7G). Most notably, no CSMN axons extended past
the pons inCtip2/mice (n 7) (Figure 7H), while CSMN mice aberrantly maintain ectopic projections to the spi-
nal cord (at 3 weeks: wt 272  39, n  5; Ctip2/ 623 axons in all wild-type and heterozygous littermates ana-
lyzed (n  20) extended normally through the medulla 23, n  4; p  0.0002; at 10 weeks: wt 333  27, n 
4; Ctip2/ 1088  403, n  5; p  0.14) (Figure 8). Intoward the pyramidal decussation and in some cases
had already entered the spinal cord by P0 (Figure 7D). contrast, the number of neurons with spinal projections
in sensorimotor cortex is the same in wild-type andTaken together, these data demonstrate that Ctip2 is
critical and necessary for CSMN to extend projections Ctip2/mice (at 3 weeks: wt 4767 507, n 5;Ctip2/
4004  223, n  4; p  0.25; at 10 weeks: wt 3977 to the spinal cord.
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Figure 7. CSMN in Ctip2/ Mice Display
Pathfinding Defects and Fail to Extend to the
Spinal Cord
(A and E) Schematic representations of sagit-
tal views of the brain and proximal spinal cord
in wild-type and Ctip2/ mice, respectively,
showing the location of CSMN somas in the
cortex (red triangles) and their axonal projec-
tions toward the spinal cord (red lines). (B–D
and F–H) Photomicrographs of boxed areas
in (A) and (E), respectively. (B and F) Axonal
projections by subcerebral projection neu-
rons showing that (B) P0 wild-type axons are
organized in typical axon fascicles (arrows),
but (F) matched P0Ctip2/ null mutant axons
are very disorganized, nonfasciculated (arrow),
and display axonal projections that deviate
from the normal pathway and extend to ec-
topic targets (arrowhead). (C andG) The same
axonal fibers as (B) and (F), at a more caudal
location. (C) Wild-type axons are highly orga-
nized in tight bundles of fibers progressing
unidirectionally toward the pons (arrow),
while (G)Ctip2/ axons are strikingly reduced
in numbers with many individual fibers extending to ectopic sites (arrowheads). (D and H) Photomicrographic montages demonstrating (D)
that P0 wild-type axons are abundant through the pons (arrows) and have already reached the pyramidal decussation entering the spinal
cord (arrowhead). (H) A much smaller number of axons in Ctip2/ mice enters the pons (arrows) and no axons extend into the medulla or
reach the pyramidal decussation. Scale bars, 100 m.
216, n  4; Ctip2/ 3911  454, n  5; p  0.91). axonal projections, taking advantage of an intrinsic ana-
tomical property (i.e., distant axonal fields) shared byThese data indicate that ctip2 plays an important role
in directing the developmental pruning and refinement many other classes of projection neurons. These ap-
proaches could thus be used to purify other neuronalof projections to the spinal cord.
Together, these results with bothCtip2/ andCtip2/ subclasses in a systematic fashion. Additionally, at each
developmental stage studied, we were able to purifymice support the hypothesis that CTIP2 is centrally in-
volved in orchestrating the complex extension, fascicu- relatively homogeneous neuronal populations in fairly
large numbers. This reduces artifacts of RNA amplifica-lation, and refinement of subcerebral axonal projections
and particularly the ability of CSMN to extend projec- tion and enhances the probability of identifying genes
that are true genetic determinants of the neuronal popu-tions to the spinal cord during the formation of the corti-
cospinal tract. lation sampled rather than differentially expressed
genes in only some of the neurons within a heteroge-
neous population. The depth and robustness of dataDiscussion
obtained using the neuronal populations that wepurified
in this manner is demonstrated by the fact that all differ-Attempts to study developmental controls over neuronal
subtypes have been hampered by the inability to distin- entially expressed genes that we further investigated
were confirmed by in situ hybridization or immunocyto-guish different types of projection neurons with distinct
and specific molecular markers. A detailed molecular chemistry (Figure 3).
anatomy of neuronal subtypes would facilitate identifi-
cation of molecular programs specifying different pro-
Identification of CSMN-Specific Genesjection neuron subtypes.
Wehypothesized that, duringCSMNdevelopment, thereHere, we report a molecular characterization of the
exist both (1) genes that are used by all cortical projec-clinically important population of CSMN at different
tion neurons to control general aspects of early projec-stages during their development in vivo. We identify a
tion neuron specification and latermorphologic differen-distinct set of largely uncharacterized genes that exhibit
tiation and (2) genes that are neuronal subtype restricteda range of progressive restriction to CSMN among other
and contribute to define the specific population ofrelated subcerebral projection neurons. These genes
CSMN. Combinatorial interactions of both of theseencode critically important molecules for proper CSMN
classes of genes, in the correct temporal order, is likelydifferentiation, as demonstrated by our experiments re-
necessary to instruct neural precursors toward avealing that lack of CTIP2 results in striking abnormali-
CSMN-specific fate.ties of axonal outgrowth and pathfinding by CSMN and
Our investigation of genes in the second class, genessubcerebral projection neurons, leading to the failure of
specific to CSMN, identified many genes that were notCSMN to connect to the spinal cord.
previously known to be expressed in CSMN (or in other
specific classes of cortical neurons) and, thus, are novelPurification and Genetic Analysis of Distinct
genetic determinants of this neuronal subtype. TheseNeuronal Subpopulations
molecules are of particular interest, as they includeDistinct classes of cortical projection neuronswere puri-
fied at different stages of development based on their genes that might be involved in different aspects of
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subcortically, although they are located within the same
cortical layer. Others of the genes reported here have
a gradient of expression in layer V, suggesting that they
are expressed by many but not all subcerebral projec-
tion neurons (e.g., Crystallin-Mu and Netrin G1).
Together, our data support a model in which CSMN
and other subcerebral projection neurons share com-
mongenetic programs that determine their specific lami-
nar position and initial outgrowth to subcerebral targets.
This model is consistent with elegant studies by O’Leary
and colleagues showing that subcerebral projection
neurons extend axons in a stereotypic pattern toward
the spinal cord with collateral branching from the pri-
mary axons and only later refine their differentiation by
pruning collateral projections and only maintaining pro-
jections to the appropriate subcortical targets (O’Leary
and Koester, 1993). We now provide direct molecular
evidence that supports and extends this hypothesis.
Importantly, in further support of a model of combina-
torial gene expression to delineate CSMN, we find that
LMO4 is expressed by callosal neurons but excluded
fromCSMN, thus representing a critical negativemarker
of CSMN and other subcerebral projection neurons. To-
gether, these genes provide the foundation for defining
the molecular anatomy of CSMN.
CSMN-Specific Genes Are Biologically Important
Confirming that the set of genes differentially expressed
by CSMN have important functions during CSMN devel-
Figure 8. Heterozygous Ctip2/ Mice Fail to Correctly Prune Sub- opment,we find thatCtip2/mice exhibit striking abnor-
cerebral Projections malities in their axonal projections to subcerebral tar-
(A andD) FG-labeled layer VCSMN in sensorimotor cortex (asterisks) gets and that Ctip2/ CSMN fail to extend projections
and lateral sensory cortex (orange boxes) in (A) wild-type and (D)
to the spinal cord. Ctip2 encodes a zinc finger DNACtip2/ heterozygous mice. (B) Higher-magnification image of the
binding protein that acts as a transcriptional repressorarea boxed in (A), showing the typical small number of residual
(Avram et al., 2000; Senawong et al., 2003). While CTIP2CSMN in lateral sensory cortex of 3-week-old wild-type mice. (E)
Higher-magnification image of the area boxed in (D), showing the was initially discovered as an interacting partner of
marked increase in the number of residual CSMN in littermate COUP-TF orphan nuclear receptors, it is unclear whether
3-week-old Ctip2/ heterozygous mice, suggesting that reduced CTIP2 interaction with COUP-TFs in vivo is required for
levels of CTIP2 limit the ability of subcerebral projection neurons to
CTIP2-mediated gene expression. No role for this geneproperly prune ectopic connections to the spinal cord. (C and F)
in the nervous system was previously known. However,Camera lucida drawings of (B) and (E), respectively. (G) At 3 weeks
prior loss-of-function experiments in vivo highlight anof age, Ctip2/ mice (blue) retain more than double the number of
CSMN in lateral sensory cortex compared to controls (red); at 3 important role for CTIP2 in cell type specification in the
weeks, p 0.0002; at 10 weeks, p 0.14. Neuron counts are shown immune system (Wakabayashi et al., 2003).
as the mean  SEM of the number of CSMN in every sixth section We find that the absence of CTIP2 in vivo results in
of lateral sensory cortex of both hemispheres.
defects in the organization and fasciculation of subcere-
bral fiber tracts, including CSMN axonal projections.
This phenotype is dramatic in the internal capsule, theCSMN development, from fate specification and migra-
tion to process outgrowth and axon guidance to cell path that CSMN axons follow during their initial out-
growth toward distal targets in the spinal cord. Mostadhesion and survival. These are the critical develop-
mental events that should be controlled in a subtype- importantly, we found that the absence of CTIP2 results
in the inability of corticospinal neurons to extend projec-specific fashion.
Of interest, the CSMN- and subcerebral-specific tions to the spinal cord, with striking pathfinding errors
along the corticospinal pathway. In addition, our obser-genes that we identify have various levels of restricted
expression. A small number appear to be restricted to vation that decreased levels of CTIP2 in heterozygous
mice results in abnormal pruning of axon collaterals tosensorimotor cortex (e.g., Diap3, Igfbp4, and Crim1),
distinguishing CSMN from other subcerebral projection the spinal cord further highlights the importance ofCtip2
during the development of CSMN connectivity. Our dataneurons. Many genes (e.g., Ctip2, Enchephalopsin, Fez,
Clim1, Pcp4, and S100a10) exhibit broader layer V ex- are supported by the observation that Coup-Tf1 null
mutant mice also have defects in axon guidance (Qiupression, strongly suggesting restriction to subcerebral
projection neurons. Indeed, we found that CTIP2 is ex- et al., 1997; Zhou et al., 1999). Interestingly, COUP-TF1
exhibits a gradient of expression across cortical areaspressed in CSMN and in closely related subtypes of
subcerebral projection neurons but is excluded from (Liu et al., 2000). We speculate that, if COUP-TF1 inter-
acts with CTIP2 in vivo, as has been shown in vitrocallosal neurons, which do not send axonal projections
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(Avram et al., 2000), the two molecules could contribute CSMNpopulation via specific combinatorial expression.
The data presented here support the idea that a preciseimportantly in defining the areal identity of subcere-
bral neurons. molecular classification of distinct classes of projection
neurons is possible andprovide a foundation for increas-
ingly sophisticated analysis of stage-specific genes con-CSMN-Specific Genes Potentially Control Distinct
trolling corticospinal motor neuron development.Aspects of CSMN Development
At least two of the CSMN-specific genes, Fez (Matsuo-
Takasaki et al., 2000; Hirata et al., 2004) andClim1 (Bach Experimental Procedures
et al., 1997), may be novel early instructive signals of
Neuronal Subtype Labeling, Dissociation, and PurificationCSMN fate specification, as suggested by their specific
All neuronal subtypes were purified from C57BL/6 mice (Charlesexpression in CSMN and by recent reports suggesting
River Laboratories,MA). CSMNwere retrogradely labeledwith green
roles in fate specification in other organisms (Becker et fluorescent microspheres (Lumafluor Corp., FL) injected into the
al., 2002; Levkowitz et al., 2003). In agreement with the pons-midbrain junction (E18), pons (P3), or cervical spinal cord at
the C2-3 or C5 level for P6 and P14, respectively. CPN were labeledCSMN-specific data that we report here, both genes
at E18, P3, P6, and P14 by injection into contralateral cortex (E17,were recently shown to be restricted to layer V, further
P1, P4, P12), as previously described (Catapano et al., 2001). CTPNsupporting our in situ and microarray data (Bulchand et
were labeled by injection into the superior colliculus of P11 pups. FGal., 2003; Inoue et al., 2004). Fez and Clim1, together
was injected into cervical spinal cord or contralateral sensorimotor
with other differentially expressed molecules identified cortex to label CSMNor callosal neurons, respectively, as previously
here (Figure 2 and Supplemental Figure S2 [http://www. described (Fricker-Gates et al., 2002). All embryonic and neonatal
pontine injections were performed using a Vevo 660 ultrasoundneuron.org/cgi/content/full/45/2/207/DC1/]), are likely
system (VisualSonics, Toronto). All animal studies were approvedto be critical for specifying CSMN fate. We hypothesize
by the Massachusetts General Hospital Institutional Animal Carethat at least some of these moleculesmight help identify
and Use Committee and performed in accordance with institutionalsubtype-specific progenitors (if they exist) or cells com-
and federal guidelines.
mitted to CSMN fate soon after mitosis. This could con- Sensorimotor cortex (CSMN and CPN) or visual cortex (CTPN)
nect the pathways we present here with the extensive were dissociated essentially as described (Catapano et al., 2001),
and microsphere-labeled CSMN, CPN, or CTPN were purified byliterature on initial neuronal specification (Rallu et al.,
FACS directly into RNAlater.2002).
A critical aspect of CSMN development is the ability
Affymetrix Microarraysto extend an extremely long axon to precise locations
RNA was extracted using the StrataPrep Total RNA Micro Kit (Stra-within the spinal cord. Here, we identify several mole-
tagene), and RNA quality was assessed using a bioanalyzer (Agilentcules specifically expressed in CSMN that might play
Technologies). RNA was amplified per Affymetrix small sample pro-
important roles in CSMN axonal growth and guidance. tocol, using two consecutive rounds of linear in vitro transcription
In addition to Ctip2, these include Netrin-G1, Neto1, to obtain 15–20g of amplified and labeled cRNA for each hybridiza-
Contactin 6, Cadherin 13, and Cadherin 22. tion (Eberwine et al., 1992). To ensure reproducibility and biological
significance, RNA samples were collected from two independentOur genetic analysis also identified molecules whose
FACS purifications at each age (biological replicates). Data fromexpression profile and identity suggests they could be
microarrays were normalized using two independent methods withinvolved in later CSMNmaturation and survival. IGFBP4
Rosetta Resolver software. Statistical significance of gene expres-
binds insulin-like growth factors and directly modulates sion differences between neuronal subtypes was determined by
IGF stability and action (Zhou et al., 2003). The estab- pairwise comparisons at each age using Significance Analysis of
lished role of IGF on cell survival (Stewart and Rotwein, Microarrays (SAM) (Tusher et al., 2001). Microarray data from the
two biological replicates were combined in Rosetta Resolver for1996), combinedwith the fact that we found that IGFBP4
trend plots. Additional details on microarray methods and analysishas a defined area-specific pattern of expression in cor-
are in the Suppplemental Data (http://www.neuron.org/cgi/content/tex, suggests that IGFBP4 may be a mediator of the
full/45/2/207/DC1/). All microarray data have been deposited in the
effects of IGF in sensorimotor cortex. Mu-Crystallin has Gene Expression Omnibus database at NCBI (Accession GSE2039).
a direct role in controlling T3 mediated gene transactiva-
tion (Mori et al., 2002). Because thyroid hormone con-
Immunocytochemistry, In Situ Hybridization,
trols important aspects of neuronal differentiation and and DiI Photoconversion
survival in the CNS (Oppenheimer and Schwartz, 1997), Brains were fixed and stained using standard methods (Fricker-
Gates et al., 2002). Primary antibodies and dilutions are detailed inMu-Crystallin could play a central role in CSMN survival.
the Supplemental Data (http://www.neuron.org/cgi/content/full/45/Of additional interest, human Mu-Crystallin maps to
2/207/DC1/). Nonradioactive in situ hybridization was performedchromosome 16 at a location near a newly identified
using reported methods (Berger and Hediger, 2001). Sense probeslocus for hereditary ALS (Sapp et al., 2003). The
were used as negative controls in all experiments. cDNA clones are
CSMN-specific expression of this gene, together with listed in Supplemental Table S1. DiI photoconversion combinedwith
the central involvement of CSMN in ALS, suggests Mu- in situ hybridization was performed as previously described (Sandell
and Masland, 1988; Fujimori et al., 2000).Crystallin as an interesting candidate gene for subtypes
of hereditary ALS.
DiI Tracing and FG Labeling in Ctip2/ and Ctip2/ Mice
Anterograde DiI tracing in vivo and in fixed tissue was performedConclusion
as previously described (Godement et al., 1987; O’Leary and Tera-In this report, we identify neuronal subtype specific
shima, 1988). CSMN in sensorimotor and lateral sensory cortex weregenes that control the development of corticospinal mo-
retrogradely labeled via FG injections in the cervical spinal cord.
tor neurons in vivo.We further study 15 particularly inter- Micewere injected at P14–P15 and sacrificed at P21 orwere injected
esting CSMN genes at the cellular, anatomic, and func- and sacrificed as 10-week-old adults. Brains were sectioned coro-
nally at 40 m, and all CSMN (in sensorimotor and in lateral sensorytional levels. We propose that these genes delineate the
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cortex) were counted in both hemispheres on every sixth section, Eberwine, J., Yeh, H., Miyashiro, K., Cao, Y., Nair, S., Finnell, R.,
Zettel, M., and Coleman, P. (1992). Analysis of gene expression inacross the entire rostrocaudal extent of the cortex.
Additional methods are given in the Supplemental Experimental single live neurons. Proc. Natl. Acad. Sci. USA 89, 3010–3014.
Procedures (http://www.neuron.org/cgi/content/full/45/2/207/DC1/). Frantz, G.D., Bohner, A.P., Akers, R.M., and McConnell, S.K. (1994).
Regulation of the POU domain gene SCIP during cerebral cortical
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